Bli medlem
Bli medlem

Du är här


Targovax ASA - Key information relating to the preferential rights issue

Reference is made to the stock exchange announcement published by Targovax ASA (the "Company") earlier today, on 4 November 2021, regarding the resolution by the Company's board of directors to propose that the Company carries out a share capital increase, by way of a fully underwritten rights issue, to raise gross proceeds of NOK 175 million (the "Rights Issue").

Date on which the terms and conditions of the preferential rights issue were announced: 4 November 2021

Last day including right: 25 November 2021

Ex-date: 26 November 2021

Record Date: 29 November 2021

Date of approval: 25 November 2021

Maximum number of new shares: 350,000,000

Subscription price: Minimum NOK 0.50 and maximum NOK 10.00

Ratio preferential rights: To be announced when final number of new shares is determined

Subscription ratio: To be announced when final number of new shares is determined

Managers: Carnegie AS and DNB Markets, a part of DNB Bank ASA

Will the rights be listed: The Company will apply for listing of the preferential rights on the Oslo Stock Exchange

ISIN for the preferential rights: To be announced when clarified

Other information: The subscription price for the new shares to be issued in the Rights Issue, and thus the final number of new shares and the exact amount of the share capital increase will be proposed by the board of directors, based on a recommendation from the Managers, the day prior to the extraordinary general meeting to be held on 25 November 2021 (the "EGM"). See the stock exchange announcement containing the notice to the EGM published earlier today, on 4 November 2021, for further information regarding the Rights Issue. The rights issue is subject to approval by the EGM.

This information is published in accordance with the requirements of the Continuing Obligations.

For further information, please contact:

Erik Digman Wiklund, CEO
Phone: +47 413 33 536

Renate Birkeli, Investor Relations
Phone: +47 922 61 624

Media enquires:
Andreas Tinglum - Corporate Communications (Norway)
Phone: +47 9300 1773

Författare Cision